EBM — Eastwood Bio-Medical Canada Balance Sheet
0.000.00%
- CA$50.98m
- CA$51.04m
- CA$0.78m
Annual balance sheet for Eastwood Bio-Medical Canada, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | 2025 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.021 | 0.04 | 0.018 | 0 | 0.018 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.006 | 0.015 | 0.083 | 0.043 | 0.015 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.058 | 0.101 | 0.151 | 0.044 | 0.033 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.55 | 0.446 | 0.338 | 0.231 | 0.186 |
| Other Long Term Assets | |||||
| Total Assets | 0.691 | 0.585 | 0.489 | 0.274 | 0.219 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.804 | 0.844 | 1.33 | 1.57 | 1.85 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.835 | 0.879 | 1.33 | 1.57 | 1.85 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -0.144 | -0.294 | -0.841 | -1.3 | -1.63 |
| Total Liabilities & Shareholders' Equity | 0.691 | 0.585 | 0.489 | 0.274 | 0.219 |
| Total Common Shares Outstanding |